Xiaoyun Wu

机构：Shenzhen Bioeasy Biotechnology (China) · ORCID：0000-0002-8261-6436

发表论文 5 篇 · 总被引 45 次 · h-index 2

代表论文

• PM 2.5 exposure contributes to anxiety and depression-like behaviors via phenyl-containing compounds interfering with dopamine receptor (2024 · Proceedings of the National Academy of Sciences · 被引 37)
• Abstract 2663: Preclinical profiling of BAY 2666605: The first PDE3A-SLFN12 complex inducer for cancer therapy (2022 · Cancer Research · 被引 3)
• Abstract ND04: BAY 2666605: The first PDE3A-SLFN12 complex inducer for cancer therapy (2022 · Cancer Research · 被引 2)
• Cryo-EM structure enabling virtual screening for the discovery of highly potent TRPM3 antagonists with analgesic efficacy (2026 · Neuron · 被引 1)
• Abstract A159: Mechanisms of uveal melanoma sensitivity to velcrin treatment and SLFN12-mediated cancer cell death (2023 · Molecular Cancer Therapeutics)